000040701 000__ 03738cam\a2200805\i\4500
000040701 001__ 40701
000040701 003__ SzGeWIPO
000040701 005__ 20230315204349.0
000040701 008__ 200401s2010\\\\gw\a\\\\ob\\\\000\0\eng\d
000040701 020__ $$a9780521116565$$qPrint
000040701 035__ $$a(MiAaPQ)EBC4830532
000040701 035__ $$a(Au-PeEL)EBL4830532
000040701 035__ $$a(CaPaEBR)ebr11366866
000040701 035__ $$a(OCoLC)980702303
000040701 035__ $$a(wipo)EBC4830532
000040701 040__ $$aMiAaPQ$$beng$$erda$$cMiAaPQ
000040701 041__ $$aeng
000040701 08204 $$a346.0486
000040701 1001_ $$aPogge, Thomas ;$$aRimmer, Matthew ;$$aRubenstein, Kim.
000040701 24510 $$aIncentives for Global Public Health :$$bPatent Law and Access to Essential Medicines.
000040701 264_1 $$aCambridge, England, UK :$$bCambridge University Press,$$c2010.
000040701 300__ $$a1 online resource (536 pages) :$$billustrations
000040701 336__ $$atext$$2rdacontent
000040701 337__ $$acomputer$$2rdamedia
000040701 338__ $$aonline resource$$bcr$$2rdacarrier
000040701 5050_ $$aIntroduction: Access to essential medicines: public health and international law -- Part I: International trade -- 1. TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis -- 2. The TRIPS Waiver as a recognition of public health concerns in the WTO -- 3. Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements -- 4. Global health and development: patents and public interest -- Part II: Innovation -- 5. The Health Impact Fund: better pharmaceutical innovations at much lower prices -- 6. The Health Impact Fund: a critique -- 7. A prize system as a partial solution to the health crisis in the developing world -- 8. Innovation and insufficient evidence: the case for a WTO–WHO Agreement on Health Technology Safety and Cost-Effectiveness Evaluation -- Part III: Intellectual property -- 9. Opening the dam: patent pools, innovation and access to essential medicines -- 10. Open Source drug discovery: a revolutionary paradigm or a Utopian model? -- 11. Accessing and benefit sharing avian influenza viruses through the World Health Organization: a CBD and TRIPS compromise thanks to Indonesia’s sovereignty claim? -- 12. The Lazarus Effect: the (RED) Campaign and creative capitalism -- Part IV: Healthcare -- 13. Beyond TRIPS: the role of non-state actors and access to essential medicines -- 14. Securing health through rights -- 15. The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India -- 16. Tipping point: Thai compulsory licences redefine essential medicines debate -- Bibliography -- Index
000040701 520__ $$aThis portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.
000040701 588__ $$aDescription based on print version record.
000040701 650_0 $$aPharmaceutical policy
000040701 650_0 $$aPatent laws and legislation
000040701 650_0 $$aDrugs$$xPatents
000040701 650_0 $$aPatents (International law)
000040701 650_0 $$aLaw$$xInternational
000040701 650_0 $$aMedical$$xHealth Policy
000040701 655_4 $$aElectronic books
000040701 85640 $$uhttps://ebookcentral.proquest.com/lib/wipo/detail.action?docID=534728$$zView this Ebook
000040701 904__ $$aBook
000040701 942__ $$2ddc$$cEBOOK
000040701 980__ $$aBIB
000040701 980__ $$aOS